References
- Schmiegelow K, Forestier E, Hellebostad M, . Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010;24:345–354.
- Calin GA, Ferracin M, Cimmino A, . A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793–1801.
- Nymark P, Guled M, Borze I, . Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Genes Chromosomes Cancer 2011;50:585–597.
- Borze I, Guled M, Musse S, . MicroRNA microarrays on archive bone marrow core biopsies of leukemias—method validation. Leuk Res 2011;35:188–195.
- Leoutsakou T, Talieri M, Scorilas A. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer. Biochem Biophys Res Commun 2006;344:667–674.
- Ma HQ, Liang XT, Zhao JJ, . Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2009;15:4844–4848.
- Carter SL, Eklund AC, Kohane IS, . A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38: 1043–1048.
- Scorilas A, Kyriakopoulou L, Katsaros D, . Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer. Br J Cancer 2001;85:190–198.
- Nakamura S, Yamashita M, Yokota D, . Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity. Invest New Drugs 2010;28: 381–391.
- Green MR, Aya-Bonilla C, Gandhi MK, . Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 2011;50:313–326.
- Ha CH, Jin ZG. Protein kinase D1, a new molecular player in VEGF signaling and angiogenesis. Mol Cells 2009;28:1–5.
- Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4–25.
- Altschmied J, Haendeler J. A new kid on the block: PKD1: a promising target for antiangiogenic therapy? Arterioscler Thromb Vasc Biol 2008;28:1689–1690.